
Private Equity Firms Bain, EQT, and TPG Enter Final Stages of Contention for UK-Based Vitabiotics at Estimated Valuation of $900 Million to $1 Billion
Vitabiotics Acquisition Talks Reach Final Stage
Private equity funds Bain Capital, EQT, and TPG are engaged in advanced discussions to acquire a stake in Vitabiotics, a UK-based nutraceutical company. The potential acquisition is expected to value Vitabiotics between $900 million and $1 billion.
The negotiations are reportedly in the final stages, with the parties working towards a definitive agreement. The exact terms of the proposed deal are not disclosed, but the valuation range indicates a significant interest in Vitabiotics from the private equity firms.
Read also: SMR Jewels IPO Successfully Lists with Institutional Support
Investor Takeaway
Investors should be aware of potential private equity activity in the nutraceutical sector.
More in IPO

SMR Jewels IPO Successfully Lists with Institutional Support

Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Merritronix IPO Sees Robust Subscription, Oversubscribed by 293 Times on Final Day
